Zai Lab stock closed at USD 25.58 before ESMO data

Published on 10/08/2026 at 02:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zai Lab stock closed at USD 25.58 on October 6, 2026, below its USD 33.97 52-week high. Q2 product revenue rose 11 percent sequentially.

ZLAB, US98887Q1040, Illustration mit AI erstellt.

Zai Lab stock (ISIN US98887Q1040) closed at USD 25.58 on Nasdaq on October 6, 2026, leaving the biotech 24.70 percent below its 52-week high of USD 33.97. The next major company checkpoint is the presentation of global zocilurtatug data at the ESMO Congress on October 26.

ESMO data sets the next checkpoint

Zai Lab announced on September 29, 2026, that its first global data from a trial of zocilurtatug pelitecan, or zoci, will be presented at ESMO. The study evaluates zoci with atezolizumab, with or without carboplatin, in first-line extensive-stage small cell lung cancer.

The company also scheduled an investor conference call for October 23, 2026, ahead of the poster presentation. The poster session is set for October 26, 2026, and covers Phase 1b/1c results from the ZL-1310-001 study.

Revenue rose sequentially in Q2

According to Benzinga on October 5, 2026, second-quarter net product revenue increased 11 percent from the prior quarter to USD 105.8 million, while the commercial business remained profitable. Management said the company is targeting a return to meaningful year-over-year growth in 2027.

MarketBeat reported quarterly revenue of USD 106.31 million and a loss of USD 0.50 per share. The revenue figure gives investors a current operating scale, while the upcoming data presentation shifts attention toward the pipeline rather than near-term earnings.

Market value remains below the yearly peak

Zai Lab had a market capitalization of USD 2.9 billion as of October 7, 2026. Its 52-week range was USD 15.96 to USD 33.97, placing the October 6 close closer to the middle of the yearly band than to its upper boundary.

Stock closed at USD 25.58

The Nasdaq-listed stock closed at USD 25.58 on October 6, 2026. The October 23 investor call and October 26 ESMO presentation are the next dated milestones for the pipeline story.